Spanish Therapeutic Positioning Reports: 6-Year Update – Increasing In Frequency But Not Relevance?

October 18, 2018 Danielle Twigg

There are 17 autonomous regions in Spain, each can make distinct price/reimbursement decisions for drugs. To drive more consistency, the Spanish Agency for Medicines and Health Products have issued national Therapeutic Positioning Reports (TPRs) for new medicines since 2012. These comparative efficacy and safety reports specify the patient population that will benefit most. This research analyses the number, indications and outcomes of TPRs.

Authors: Richard Macaulay, Raquel Fernandez Dacosta

To find out more about this poster you can register to download it here after the ISPOR event.

Previous Article
The Impact Of Landmark Response On Overall Survival: Implications For The Economic Evaluation Of Immune-Therapy (I-O) Treatment
The Impact Of Landmark Response On Overall Survival: Implications For The Economic Evaluation Of Immune-Therapy (I-O) Treatment

Next Article
Pricing And Reimbursement Reforms In Spain – A Systematic Analysis Of National Pricing Decisions By The CIPM
Pricing And Reimbursement Reforms In Spain – A Systematic Analysis Of National Pricing Decisions By The CIPM